Overview
Seiichi Kakegawa practices in Kanazawa, Japan. Mr. Kakegawa is rated as an Experienced expert by MediFind in the treatment of Pulmonary Sequestration. His top areas of expertise are Lung Adenocarcinoma, EGFR Positive Lung Cancer, Lung Cancer, and Mediastinal Tumor.
His clinical research consists of co-authoring 36 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pulmonary Sequestration.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerMr. Kakegawa isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaMr. Kakegawa isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerMr. Kakegawa isAdvanced. Learn about Lung Cancer.
- Mediastinal TumorMr. Kakegawa isAdvanced. Learn about Mediastinal Tumor.
- Experienced
- Cutaneous T-Cell Lymphoma (CTCL)Mr. Kakegawa isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Fibrosing MediastinitisMr. Kakegawa isExperienced. Learn about Fibrosing Mediastinitis.
- HypersplenismMr. Kakegawa isExperienced. Learn about Hypersplenism.
- MediastinitisMr. Kakegawa isExperienced. Learn about Mediastinitis.
- Mycosis FungoidesMr. Kakegawa isExperienced. Learn about Mycosis Fungoides.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Kakegawa isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).